The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.

项目总结/摘要： 加强努力，改善低资源国家癌症的早期发现、诊断和治疗 已经导致癌症存活率的适度改善，并导致癌症人口的扩大 幸存者然而，在低资源国家，对癌症存活率的理解存在差距。的 该提案的目的是测量Kaposi癌症幸存者的健康相关生活质量（HRQoL） 肉瘤（KS）和淋巴瘤在马拉维的癌症护理的连续性。根据NCI的定义， 癌症幸存者，我们的幸存者人口包括任何从癌症诊断的时间， 通过生命的平衡来诊断。我们假设：a）KS和淋巴瘤幸存者将有差异 在HRQoL的心理健康和身体功能领域中，治疗前（前）、治疗期间（中）和治疗后1年内 （后）癌症定向治疗;和B）在短期（<20天）治疗后HRQoL中没有差异。 自治疗完成后1年）、中期（自治疗完成后≥1-5年）或长期（> 5 治疗完成后一年）幸存者。

PROJECT SUMMARY/ABSTRACT: Increasing efforts to improve early detection, diagnosis, and treatment of cancers in low resourced countries have led to modest improvements in cancer survival and given rise to an expanding population of cancer survivors. However, there is a gap in the understanding of cancer survivorship in low resourced countries. The goal of this proposal is to measure health-related quality of life (HRQoL) for cancer survivors with Kaposi sarcoma (KS) and lymphoma across the continuum of cancer care in Malawi. In line with NCI's definition of a cancer survivor, our survivor population includes any individual diagnosed with cancer from the time of diagnosis through the balance of life. We hypothesize that: a) KS and lymphoma survivors will have differences in mental health and physical function domains of HRQoL before (pre-), during (mid-), and up to 1 year after (post-) cancer-directed treatment; and b) there is no difference in post-treatment HRQoL among short-term (< 1 year since treatment completion), medium-term (≥1-5 years since treatment completion) or long-term (> 5 year since treatment completion) survivors.